Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand
Authors:
- 1 May 2018
- journal article
- research article
- Published by Wiley in Nephrology
- Vol. 24 (3) , 308-315
Abstract
Aim: While the prevalence of end stage kidney disease in New Zealand (NZ) is well defined, the prevalence of chronic kidney disease (CKD) in NZ is unknown. To estimate the prevalence of and risk factors for CKD in the southern region of New Zealand.Methods: A retrospective electronic health record cohort study using data from the Southern Primary Care register covering 94% of the population. Patients, 20 years or older were identified and linked to laboratory results for serum creatinine and urinary albumin excretion. Chronic kidney disease was defined as an estimated glomerular filtration rate of less than 60 mL/min per 1.73 m2 (G3‐5) or the presence of albuminuria of greater than 3 mg/mmol (A2‐3). Diabetes was identified from a national virtual diabetes database. From this, we estimated the prevalence of CKD by age, gender, ethnicity, deprivation and the presence of diabetes mellitus.Results: Of a total adult population of 211 980, 159 799 had a serum creatinine checked and 27 905 had an estimate of albuminuria. The estimated prevalence of CKD was 11.8%. 6.3% of total population had CKD stage G3a, 2.4% G3b, 0.8% G4, 0.2% G5, 1.8% A2 albuminuria and 0.3% A3 albuminuria. Increasing age, female sex, ethnic group, social deprivation and diabetes mellitus were associated with an increased risk of CKD. 11 351 patients had a diagnosis of diabetes mellitus and were almost universally tested (99.3%) for CKD. The presence of albuminuria was strongly correlated with ethnic group, male sex and living in a deprived area. The retrospective electronic health record study with associated selection and testing bias are potential limitations of the present study.Conclusion: Chronic kidney disease prevalence in this region appears to be similar to other reported populations. The majority of those at risk for CKD were tested for reduced eGFR. The presence of albuminuria, an integral component of CKD diagnostic criteria, was under utilized in the non‐diabetic population.Keywords
Funding Information
- Otago Medical Research Foundation (Summer Studentship)
This publication has 18 references indexed in Scilit:
- Cost-effectiveness of Primary Screening for CKD: A Systematic ReviewAmerican Journal of Kidney Diseases, 2014
- KHA‐CARI Guideline: Early chronic kidney disease: Detection, prevention and managementNephrology, 2013
- Increased prevalence of albuminuria among non-European peoples with type 2 diabetesNephrology Dialysis Transplantation, 2011
- The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference reportKidney International, 2011
- Comparison of the Prevalence and Mortality Risk of CKD in Australia Using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR Estimating Equations: The AusDiab (Australian Diabetes, Obesity and Lifestyle) StudyAmerican Journal of Kidney Diseases, 2010
- Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in DiabetesJournal of the American Society of Nephrology, 2009
- An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) StudyDiabetologia, 2004
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Prevalence of Kidney Damage in Australian AdultsJournal of the American Society of Nephrology, 2003
- Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination surveyAmerican Journal of Kidney Diseases, 2003